University of Cambridge > Talks.cam > Early Cancer Institute Events > Novel tools for lung cancer early diagnosis and therapy

Novel tools for lung cancer early diagnosis and therapy

Add to your list(s) Download to your calendar using vCal

  • UserDr Robert Rintoul: Consultant respiratory physician in thoracic oncology at Papworth Hospital, Cambridge and Honorary Visiting Senior Fellow in the University of Cambridge and Dr Daniel Muñoz-Espin: Group Leader, Early Detection Programme.
  • ClockMonday 24 April 2017, 17:00-18:30
  • HouseMaxwell Centre, Cavendish Laboratory.

If you have a question about this talk, please contact Catherine Atkins.

To sign up go to: https://www.eventbrite.co.uk/e/novel-tools-for-lung-cancer-early-diagnosis-and-therapy-tickets-33392843895

Join the Early Detection programme of the CRUK Cambridge Centre for the first in a series of ideas sharing events to encourage collaboration between clinicians and basic scientists. These events build on our recently published infographics factsheets, which highlight key areas of physical sciences research in Cambridge that could in future improve early cancer detection.

Speakers: Dr Robert Rintoul: Consultant respiratory physician in thoracic oncology at Papworth Hospital, Cambridge and Honorary Visiting Senior Fellow in the University of Cambridge. Robert is currently the lead clinician for cancer at Papworth Hospital and Director of the Papworth Hospital Clinical Trials Unit Collaboration. The focus of his work is around clinical trials and translational research in malignant mesothelioma and the early detection of lung cancer.

Dr Daniel Muñoz-Espin: Group Leader, Early Detection Programme. Daniel’s laboratory focuses on the fundamental mechanisms and processes that lie at the origin of lung cancer. In particular, the interplay between cellular senescence and cellular plasticity, and the role of cancer stem cells. He aims to translate this knowledge using diagnostic and therapeutic tools based on novel mesoporous silica nanoparticles targeted to senescent cells.

Refreshments will be provided. To sign up go to: Join the Early Detection programme of the CRUK Cambridge Centre for the first in a series of ideas sharing events to encourage collaboration between clinicians and basic scientists. These events build on our recently published infographics factsheets, which highlight key areas of physical sciences research in Cambridge that could in future improve early cancer detection.

Speakers: Dr Robert Rintoul: Consultant respiratory physician in thoracic oncology at Papworth Hospital, Cambridge and Honorary Visiting Senior Fellow in the University of Cambridge. Robert is currently the lead clinician for cancer at Papworth Hospital and Director of the Papworth Hospital Clinical Trials Unit Collaboration. The focus of his work is around clinical trials and translational research in malignant mesothelioma and the early detection of lung cancer.

Dr Daniel Muñoz-Espin: Group Leader, Early Detection Programme. Daniel’s laboratory focuses on the fundamental mechanisms and processes that lie at the origin of lung cancer. In particular, the interplay between cellular senescence and cellular plasticity, and the role of cancer stem cells. He aims to translate this knowledge using diagnostic and therapeutic tools based on novel mesoporous silica nanoparticles targeted to senescent cells.

To sign up go toJoin the Early Detection programme of the CRUK Cambridge Centre for the first in a series of ideas sharing events to encourage collaboration between clinicians and basic scientists. These events build on our recently published infographics factsheets, which highlight key areas of physical sciences research in Cambridge that could in future improve early cancer detection.

Speakers: Dr Robert Rintoul: Consultant respiratory physician in thoracic oncology at Papworth Hospital, Cambridge and Honorary Visiting Senior Fellow in the University of Cambridge. Robert is currently the lead clinician for cancer at Papworth Hospital and Director of the Papworth Hospital Clinical Trials Unit Collaboration. The focus of his work is around clinical trials and translational research in malignant mesothelioma and the early detection of lung cancer.

Dr Daniel Muñoz-Espin: Group Leader, Early Detection Programme. Daniel’s laboratory focuses on the fundamental mechanisms and processes that lie at the origin of lung cancer. In particular, the interplay between cellular senescence and cellular plasticity, and the role of cancer stem cells. He aims to translate this knowledge using diagnostic and therapeutic tools based on novel mesoporous silica nanoparticles targeted to senescent cells.

Refreshments will be provided. To sign up go to: https://www.eventbrite.co.uk/e/novel-tools-for-lung-cancer-early-diagnosis-and-therapy-tickets-33392843895

This talk is part of the Early Cancer Institute Events series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity